학술논문
Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma.
Document Type
Article
Author
Source
Antioxidants; Jun2023, Vol. 12 Issue 6, p1313, 24p
Subject
Language
ISSN
20763921
Abstract
Copyright of Antioxidants is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)